John Jumper Leaves Google DeepMind for Anthropic Amid Intensifying AI Talent Race 
Kingboard Holdings Shares Surge After HK$11.77 Billion Block Trade to Expand PCB and AI Supply Chain Business 
Meta Seeks Legal Shield From Child-Harm Lawsuits Amid KOSA Talks 
Apple Signals Product Price Hikes Amid Rising Memory Chip Costs 
Samsung Gains Interest from BYD, Google, AMD as AI Chip Demand Strains TSMC Capacity 
GM and Lockheed Martin Partner to Strengthen U.S. Defense Manufacturing Capacity 
Saudi Aramco Explores Sulphur Business Stake Sale to Raise Billions 
SK Hynix Shares Hit Record High After Shipping Next-Generation HBM4E AI Memory Samples 
HSBC Australia Faces A$35M Penalty Over Scam Protection Failures 
Jio IPO Filing Nears as Reliance Targets $4 Billion Market Debut 
Frank Stronach Found Guilty of Sexual Assault and Indecent Assault in Ontario Court 
Qantas Nears Launch of World’s Longest Non-Stop Flights to London and New York 
Ukrainian Drone Makers Target Japan and Asia Defense Market 
Trump Administration Delays DeepSeek and CXMT Trade Blacklist Designations Amid U.S.-China Tensions 
Obayashi to Acquire Multiplex in $526M Expansion Deal 
Chinese Social Media Giant Xiaohongshu Eyes Hong Kong IPO at Over $70 Billion Valuation 
SoftBank Shares Drop as OpenAI Losses and Rising Costs Spark Investor Concerns 
PLEASANTON, Calif., Jan. 07, 2016 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE:COO) today announced that, consistent with the plan approved by its board of directors to pay annual dividends, the Company declared a semi-annual dividend of 3 cents per share, payable on February 9, 2016, to stockholders of record on January 22, 2016.
About The Cooper Companies
The Cooper Companies, Inc. ("Cooper") is a global medical device company publicly traded on the NYSE Euronext (NYSE:COO). Cooper is dedicated to being A Quality of Life Company™ with a focus on delivering shareholder value. Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical focuses on supplying women's health clinicians with market-leading products and treatment options to improve the delivery of health care to women. Headquartered in Pleasanton, CA, Cooper has approximately 10,000 employees with products sold in over 100 countries. For more information, please visit www.coopercos.com.
COO-D
Kim Duncan Vice President, Investor Relations [email protected] 925-460-3663
